SCHEMBL455325

SCHEMBL455325

CCc1cc[c]c(Cl)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2005701 0.83 CNR2 (0.39)
SCHEMBL4432930 0.79 SKP2 (0.42)
SCHEMBL10367130 0.79
SCHEMBL6300221 0.78 PTGS2 (0.41)
SCHEMBL2128069 0.77
SCHEMBL1631246 0.77
SCHEMBL14935565 0.77
SCHEMBL2497498 0.77 HRH3 (0.45)
SCHEMBL6299128 0.77 GABRA1 (0.40)
SCHEMBL2500621 0.77 KDM4E (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104169003-A Catalyst systems for preparing 1-hexene and/or 1-octene from ethylene SK INNOVATION CO LTD 2014-11-26 CN claimed
US-8071625-B2 E.g., [(1-(2-aminoacetyl)-4-{N-[(3-fluoro-2-methylphenyl)methyl]carbamoyl}(4-piperidyl))methoxy]-N-(4-ethylphenyl)carboxamide; smooth muscle myosin or non-muscle myosin modulator; hypotensive agent; asthma, COPD, bronchoconstrictive disease, glaucoma, pre-menstrual cramps, erectile dysfunction CYTOKINETICS, INC. (US) 2011-12-06 US claimed
US-20080234259-A1 Novel Cannabinoid Receptor Ligands, Pharmaceutical Compositions Containing Them, and Process For Their Preparation GLENMARK PHARMACEUTICALS S.A. (CH) 2008-09-25 US claimed
WO-2008016676-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INCORPORATED (US) 2008-02-07 WO claimed
EP-0805677-B1 EXTENDED RELEASE CLONIDINE FORMULATION HORACEK H JOSEPH (US) 2005-06-15 EP claimed
EP-0256798-B1 ANAESTHETIC COMPOSITION Anaquest, Inc. (US) 1991-09-25 EP claimed
US-4859685-A Anesthetic composition and method of using the same BOC, INC. (US) 1989-08-22 US claimed
EP-0256798-A1 Anaesthetic composition Anaquest, Inc. (US) 1988-02-24 EP claimed
US-4629495-A Herbicidal 5-amino-4-cyano-1-phenylpyrazoles MAY & BAKER LIMITED (GB) 1986-12-16 US claimed
WO-2020061412-A1 COMPOUNDS WITH COPPER- OR ZINC-ACTIVATED TOXICITY AGAINST MICROBIAL INFECTION KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2020-03-26 WO disclosed
US-20200031778-A1 NOVEL 5-SUBSTITUTED IMIDAZOLYLMETHYL DERIVATIVES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-01-30 US disclosed
EP-3045450-B1 INTERMEDIATE COMPOUNDS IN PROCESSES FOR PRODUCING PYRIDAZINONE COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2018-02-07 EP disclosed
WO-2016145614-A1 TRIAZOLYL PYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-09-22 WO disclosed
CN-104326952-B Prepare method and its intermediate of pyridazinone compound 住友化学株式会社 2016-08-24 CN disclosed
EP-0327808-A1 Substituted 3-aminosydnonimines, process for their preparation and their use CASSELLA Aktiengesellschaft (DE) 1989-08-16 EP disclosed
EP-0256798-A1 Anaesthetic composition Anaquest, Inc. (US) 1988-02-24 EP disclosed
US-4629495-A Herbicidal 5-amino-4-cyano-1-phenylpyrazoles MAY & BAKER LIMITED (GB) 1986-12-16 US disclosed
EP-0031295-B1 ORGANIC ANTIMONY-SULPHUR COMPOUNDS, THEIR USE AS STABILISERS IN CHLORIC THERMOPLASTICS, AND THERMOPLASTICS SO STABILISED CIBA-GEIGY AG (CH) 1983-05-18 EP disclosed
US-4367304-A Novel organic antimony-sulfur compounds and their use as stabilizers for chlorine-containing thermoplasts CIBA-GEIGY CORPORATION (US) 1983-01-04 US disclosed
US-4190602-A PHOTOCHEMICAL SENSITIZERS BY REACTION OF SULFUROUS ACID ESTER OR THIONYL CHLORIDE AND A PRIMARY ALCOHOL CIBA-GEIGY CORPORATION (US) 1980-02-26 US disclosed